FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Hetero Montelukast sodium tablets Recall

Montelukast sodium tablets, 10 mg, 30-count bottle, Rx Only, Manufactured for: Camber P…

Hetero USA Inc · Piscataway, NJ

Risk level
Class III
Reported by FDA
Apr 5, 2017
Recall ID
D-0623-2017
Check your lot numberHow we source this data

Summary

Hetero recalled Montelukast sodium tablets starting Jan 7, 2017. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0623-2017 on Apr 5, 2017. Reason: Discoloration: the firm received a complaint of a sealed bottle in which tablets inside had blue spots and a blue powder inside the bottle. Status: Terminated.

Why it was recalled

Discoloration: the firm received a complaint of a sealed bottle in which tablets inside had blue spots and a blue powder inside the bottle.

Product description

Montelukast sodium tablets, 10 mg, 30-count bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: HETERO Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, NDC 31722-726-30

Lot numbers, UPCs & expiration codes

Lot # MON16001B, Exp 01/18

Where it was sold

US Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0623-2017
Classification
Class III
Status
Terminated
Recall initiated
Jan 7, 2017
FDA report date
Apr 5, 2017
Quantity
65,664 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Hetero USA Inc

Original FDA data

Every field from FDA enforcement report D-0623-2017, exactly as published.

Show all FDA fields
City
Piscataway
State
NJ
Status
Terminated
Country
United States
Event ID
76412
Address
1035 Centennial Ave
Code information
Lot # MON16001B, Exp 01/18
Postal code
08854-4124
Report date
Apr 5, 2017
Product type
Drugs
Recall number
D-0623-2017
Classification
Class III
Recalling firm
Hetero USA Inc
Product quantity
65,664 bottles
Termination date
Aug 8, 2017
Reason for recall
Discoloration: the firm received a complaint of a sealed bottle in which tablets inside had blue spots and a blue powder inside the bottle.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Montelukast sodium tablets, 10 mg, 30-count bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: HETERO Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, NDC 31722-726-30
Distribution pattern
US Nationwide
Recall initiation date
Jan 7, 2017
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Mar 29, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0623-2017, published Apr 5, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls